» Articles » PMID: 31290758

Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer

Overview
Date 2019 Jul 11
PMID 31290758
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-infiltrating lymphocytes (TILs) have shown a promising prognostic value in many epithelial cancers. We sought to assess the prognostic value of TILs in a multicenter cohort of early oral tongue squamous cell carcinoma (OTSCC). The percentage of TILs was assessed on the surgical resection slides stained with hematoxylin and eosin. The assessment of TILs was performed in the stromal compartment and in the intraepithelial compartment (at the invasive front and at the center of the tumor). We followed the method that was described recently by the International Immuno-Oncology Biomarker Working Group for the assessment of TILs. A total of 308 cases from the 5 Finnish university hospitals and from A.C. Camargo Cancer Center, São Paulo, Brazil, were included. We found a promising prognostic value for stromal TILs at the invasive front in the multivariable analysis with a hazard ratio of 2.61 (95% confidence interval [CI], 1.77-3.83; P<0.001) for overall survival, 1.99 (95% CI, 1.07-3.69; P=0.040) for disease-specific survival, and 1.94 (95% CI, 1.14-3.29; P=0.020) for disease-free survival. In conclusion, evaluation of TILs is simple and can aid in identifying the high-risk cases of early OTSCC. The method introduced by the International Immuno-Oncology Biomarker Working Group can be used for standardized determination of TILs in early OTSCC.

Citing Articles

Investigating Tumor-Infiltrating Lymphocytes in the Microenvironment of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMDs): Can They Shift Our Perspective? A Scoping Review.

Sutera S, Furchi O, Pentenero M J Clin Med. 2025; 14(2).

PMID: 39860614 PMC: 11766165. DOI: 10.3390/jcm14020606.


Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.

Almangush A, Alabi R, Pirinen M, Makitie A, Leivo I BMC Cancer. 2024; 24(1):1517.

PMID: 39696123 PMC: 11658108. DOI: 10.1186/s12885-024-13317-z.


Integrative analysis of H&E and IHC identifies prognostic immune subtypes in HPV related oropharyngeal cancer.

Nakkireddy S, Jang I, Kim M, Yin L, Rivera M, Garcia J Commun Med (Lond). 2024; 4(1):190.

PMID: 39363031 PMC: 11450009. DOI: 10.1038/s43856-024-00604-w.


Tumor Microenvironment-Based Risk Stratification of Oropharyngeal Squamous Cell Carcinoma.

Almangush A, Jouhi L, Haglund C, Hagstrom J, Makitie A, Leivo I Head Neck. 2024; 47(2):599-605.

PMID: 39340223 PMC: 11717971. DOI: 10.1002/hed.27945.


Ferroptosis and oral squamous cell carcinoma: connecting the dots to move forward.

Antonelli A, Battaglia A, Sacco A, Petriaggi L, Giorgio E, Barone S Front Oral Health. 2024; 5:1461022.

PMID: 39296524 PMC: 11408306. DOI: 10.3389/froh.2024.1461022.